Skip to main content

Table 1 Baseline characteristics of participants

From: Association between novel arterial stiffness indices and risk factors of cardiovascular disease

No. of subjects 7248  
Sex   
  Male 4083 [56.3]
  Female 3165 [43.7]
Age (years) 45.5 ± 5.8  
Height (cm) 165.1 ± 8.5  
BMI (kg/m2) 23.8 ± 4.1  
Abdominal circumference (cm) 82.7 ± 10.5  
sBP (mmHg) 120.5 ± 15.8  
dBP (mmHg) 77.5 ± 10.7  
HR (/min) 66.1 ± 9.4  
Hemoglobin (g/dL) 14.5 ± 1.8  
Total protein (g/dL) 7.1 ± 0.4  
Albumin (g/dL) 4.4 ± 0.2  
eGFR (%) 76.6 ± 12.5  
AST (IU/L) 21.8 ± 12.3  
ALT (IU/L) 24.9 ± 20.0  
FPG (mg/dL) 103.0 ± 20.6  
HbA1c (NGSP, %) 5.5 ± 0.7  
Total cholesterol (mg/dL) 203.2 ± 34.2  
LDL cholesterol (mg/dL) 125.1 ± 33.6  
HDL cholesterol (mg/dL) 65.4 ± 17.8  
Triglyceride (mg/dL) 117.3 ± 108.6  
Hypertension 668 [9.2]
Diabetes mellitus 286 [3.9]
Dyslipidemia 393 [5.4]
Medications   
  Antihypertension 634 [8.7]
  Antidiabetes 219 [3.0]
  Lipid-lowering 346 [4.7]
Family history of hypertension 2242 [30.9]
Current smoker 2531 [34.9]
API 25.1 ± 7.0  
AVI 16.6 ± 5.4  
  1. Data are means ± SD or n [%]. Abbreviations: BMI body mass index, sBP systolic blood pressure, dBP diastolic BP, HR heart rate, eGFR estimated glomerular filtration rate, AST aspartate aminotransferase, ALT alanine aminotransferase, FPG fasting plasma glucose, HbA1c hemoglobin A1c, LDL low density lipoprotein, HDL high density lipoprotein, SD standard deviation